These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20350627)

  • 1. Immuno-positron emission tomography in cancer models.
    Reddy S; Robinson MK
    Semin Nucl Med; 2010 May; 40(3):182-9. PubMed ID: 20350627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody vectors for imaging.
    Olafsen T; Wu AM
    Semin Nucl Med; 2010 May; 40(3):167-81. PubMed ID: 20350626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies.
    Malviya G; Conti F; Chianelli M; Scopinaro F; Dierckx RA; Signore A
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):386-98. PubMed ID: 19777175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
    Sharkey RM; Karacay H; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5577s-5585s. PubMed ID: 17875792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-PET for Clinical Theranostic Approaches.
    Bailly C; Cléry PF; Faivre-Chauvet A; Bourgeois M; Guérard F; Haddad F; Barbet J; Chérel M; Kraeber-Bodéré F; Carlier T; Bodet-Milin C
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and inflammation imaging.
    Malviya G; Signore A
    Nucl Med Biol; 2014 Jul; 41(6):488. PubMed ID: 24768144
    [No Abstract]   [Full Text] [Related]  

  • 8. Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging.
    Pecking AP; Bellet D; Alberini JL
    Clin Exp Metastasis; 2012 Oct; 29(7):847-52. PubMed ID: 22760521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging (PET) of brain tumors.
    Basu S; Alavi A
    Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-PET for tumor targeting.
    Lee FT; Scott AM
    J Nucl Med; 2003 Aug; 44(8):1282-3. PubMed ID: 12902419
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of clinical radioimmunodetection of human tumors.
    Larson SM; Divgi CR; Scott AM
    Cancer; 1994 Feb; 73(3 Suppl):832-5. PubMed ID: 8306267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Perspectives on
    Yoon JK; Park BN; Ryu EK; An YS; Lee SJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560337
    [No Abstract]   [Full Text] [Related]  

  • 13. Human reporter genes: potential use in clinical studies.
    Serganova I; Ponomarev V; Blasberg R
    Nucl Med Biol; 2007 Oct; 34(7):791-807. PubMed ID: 17921031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Immuno-PET in Antibody-Drug Conjugate Development.
    Carmon KS; Azhdarinia A
    Mol Imaging; 2018; 17():1536012118801223. PubMed ID: 30370812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on oncologic imaging with radiolabeled antibodies.
    Goldenberg DM
    Cancer; 1997 Dec; 80(12 Suppl):2431-5. PubMed ID: 9406694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New agents and techniques for imaging prostate cancer.
    Zaheer A; Cho SY; Pomper MG
    J Nucl Med; 2009 Sep; 50(9):1387-90. PubMed ID: 19690043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Immuno-PET for the Detection of Cancer and Assessment of Response to Therapy.
    Alauddin MM; Khawli LA
    Curr Med Chem; 2021; 28(4):647-672. PubMed ID: 32003655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zr-89 Immuno-PET Targeting Ectopic ATP Synthase Enables In-Vivo Imaging of Tumor Angiogenesis.
    Park BN; Kim GH; Ko SA; Shin GH; Lee SJ; An YS; Yoon JK
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.